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Renal hypertrophy in streptozotocin diabetic rats: Role of proteolytic
lysosomal enzymes. Renal protein mass increases in diabetic renal
hypertrophy. Accretion of protein may be the result of increased
protein synthesis and/or decreased protein degradation. The lysosomtil
proteases, cathepsins B and L, are key enzymes in cellular protein
catabolism. To evaluate the role of protein degradation in diabetic renal
hypertrophy, the activities of cathepsins B and L were measured in
microdissected proximal tubule segments and in kidney cortex homoge-
nates. In rats four and ten days following induction of diabetes by
streptozotocin, the kidney weight was increased and the cathepsin
activities were reduced in proximal tubule segments. Treatment with
insulin prevented both changes. The liver weight in diabetic rats was
decreased and the activity of cathepsins B and L was increased, while
the activity in kidney cortex was reduced. This excluded that diabetes
per se may be accompanied by decreased cathepsin activities indepen-
dent of organ hypertrophy. Renal hypertrophy as a cause rather than as
the consequence of reduced cathepsin activities was excluded by the
finding of unchanged cathepsin activities in proximal tubule segments
from rats with compensatory renal hypertrophy four days and ten days
following unilateral nephrectomy. Decreased activities of cathepsins B
and L may reflect decreased intracellular protein degradation. De-
creased protein breakdown in proximal tubules may contribute to
diabetic renal hypertrophy. In agreement with this interpretation are the
results from rats six months following induction of diabetes. Renal
hypertrophy is complete at that time. No further accretion of protein
occurs and the cathepsin activities ip the proximal tubule were not
different from controls.
The kidney size is increased in the initial phase of human type
I diabetes and in early experimental diabetes in rats [1, 21.
Diabetic renal hypertrophy is associated with an increase in
renal protein mass [2—5]. Accretion of protein may be the result
of increased protein synthesis and/or decreased protein catab-
olism. Protein synthesis as well as protein degradation are
energy dependent processes [6]. Hence, decreased cell protein
breakdown would be an energy saving mechanism to increase
kidney protein mass. The lysosomes are generally believed to
play a major role in the breakdown of proteins in mammalian
cells [6—10]. Protein degradation by the lysosomal system
involves sequestration of intracellular proteins in autophagic
vacuofes, fusion of these vacuoles with primary lysosomes, and
degradation of proteins within the newly formed secondary
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lysosomes by proteinases. Highly active lysosornal proteinases
are the cathepsins B and L. Inhibition of cathepsins B and L
inhibits intracellular protein degradation by up to 70% 1$, 9]. To
evaluate the role of lysosomal proteolysis in diabetic renal
hypertrophy the activities of cathepsins B and L were measured
in kidneys from rats with streptozotocin-induced diabetes, from
control rats, and from streptozotocin-injected rats treated with
insulin. Renal hypertrophy in streptozotocin-injected rats was
prevented by insulin treatment. To evaluate the possibility that
hypertrophy per se may be accompanied by changes in activity
of cathepsins B and L, the enzymes were determined in
hypertrophic kidneys from rats following unilateral nephrec-
tomy. Since renal hypertrophy involves mainly kidney cortex
and proximal tubule is the major component of kidney cortex
[2], enzyme activities were determined in kidney cortex ho-
mogenates and in microdissected segments of the proximal
tubule. For comparison, the activity of cathepsins B and L was
also measured in liver homogenates from diabetic and non-
diabetic rats.
Methods
Experimental animals
Eight- to ten-week-old female Sprague-Dawley rats weighing
180 to 250 g were studied (Central Animal Laboratory, Medical
School Hannover, Germany). The animals were housed in
metabolic cages and had free access to standard rat chow
(Altromin, Spezialfutter GmbH, Lage, Germany) and tap wa-
ter.
Experimental protocol
Diabetes was induced by intravenous injection of streptozo-
10cm (60 mg/kg body wt), in I ml of 0.1 mol/liter citrate buffer,
pH 5; (Sigma Chemical Company, St. Louis, Missouri, USA).
Rats with urine glucose lower than 3 g/24 hr were not included.
Controls received I ml of citrate buffer only. Nine experimental
groups were studied. Groups Ito 6 consisted of rats four days,
ten days, and six months following induction of diabetes and
their respective controls. Group 7 was comprised of rats ten
days following injection of streptozotocin treated with s.c.
insulin, 2 x 4 units per day, beginning at day two. Depot insulin
was used (Hoechst AG, Hoechst, Germany) which contains
aminochinuridedihydrochioricle (ACDC) as depot body and
methyl-4-hydroxybenzoate (MHB) as the preservative. To eval-
uate possible effects of both substances on enzyme activities, a
group often day control rats was injected with ACDC and MHB
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in a dose and time schedule equivalent to insulin injection.
Groups 8, 9, 10, and 11 consisted of rats four days following
unilateral nephrectomy, rats ten days following unilateral ne-
phrectomy, and rats four and ten days following sham opera-
tion. In all groups, kidney weight, creatinine clearance, urine
protein, and activities of cathepsins B and L in proximal tubule
segments were measured. In separate animals of the three
groups ten days following induction of diabetes—controls,
diabetics, diabetics with insulin—right kidney water content,
left kidney protein content and activities of cathepsins B and L
in kidney cortex homogenates were determined. In ten day
diabetic rats and in controls, liver weight, liver protein and liver
activities of cathepsins B and L were measured for comparison.
Twenty-four hours prior to the experiments urine was collected
and creatinine clearance and glucosuria were determined.
Determination of creatinine, protein, glucose, and kidney
water content
Creatinine in urine and plasma was determined using the
picric acid method (Beckman Creatinine Analyzer 2, Fullerton,
California, USA). Protein in urine, kidney and liver homoge-
nates was determined by Lowry's method using bovine albumin
as standard [11]. Glucose in urine and blood was determined by
the hexokinase/G6P-DH-method (Gluco-quant, Boehringer
Mannheim GmbH, Mannheim, Germany). The dry weight of
the right kidney was determined after four hours of desiccation
in an oven at 125°C. The difference between wet and dry weight
was assumed to be the water content of the kidney.
Preparation of homogenates from kidney cortex and liver
The animals were killed by stunning and cervical dislocation.
Blood was withdrawn by cardiac puncture. Both kidneys and
the liver were removed rapidly and immersed in ice-cold
dissection solution. Previously weighed samples of kidney
cortex (0.4 to 0.6 g) and liver (0.5 to 1.1 g) were minced and
repeatedly frozen in dry ice and thawed. The samples were
homogenized in 20 ml of a 10 mmolar phosphate buffer, pH 7.4,
using a cooled Sorvall Omni-Mixer four times for four minutes
at 50,000 RPM. Kidney cortex homogenate was further diluted
1:100 for cathepsins B and L determination and 1:30 for protein
determination. Liver homogenate was diluted 1:50 for cathepsin
and protein determinations.
Determination of cathepsins B and L in isolated segments of
proximal tubules and in homogenates from kidney cortex and
liver
The combined activities of cathepsins B and L in isolated
tubule segments was measured by means of a fluorometric
microassay as published recently [11]. Z-phenylalanyl-arginine-
7-amido-4-methylcoumarin (Z-Phen-Arg-NMec) was used as
substrate for cathepsins B and L together. The enzymes cleave
the substrate and release 7-amino-4-methylcoumarin (NMec),
which is highly fluorescent and can be measured at very low
concentrations in small fluid volumes. The substrate is specific
for cathepsins B and L [11].
Solutions
All solutions were prepared from glass distilled water to
reduce background fluorescence. All chemicals were reagent
grade. The dissection solution contained (in mmollliter): NaC1,
136; KCI, 3; MgSO4, 1.2; K2HPO4, 1; CaCl2, 2; sodium lactate,
4; sodium citrate, I; L-alanine, 6; and glucose 5.5. The colla-
genase solution was identical to the dissection solution except
for the addition of 0.1% collagenase (Sigma, Type I). The
rinsing solution contained (in mmol/liter): Na2HPO4, 11.5;
KH2PO4, 55.2; and EDTA, 4. The pH was 6.0 and the osmo-
lality was 141 mOsm/kg H20. The preincubation solution was
the same as the rinsing solution but, in addition, contained 0.2%
Triton X100 (Sigma) and 0.05% bovine serum albumin (Sigma).
The substrate, Z-Phen-Arg-NMec, was obtained from Bachem
Feinchemikalien, Bubendorf, Switzerland. A 10 mmolar stock
solution of the substrate was prepared in DMSO (dimethyl
suiphoxide). This stock solution was diluted daily to a 1 mmolar
solution with 0.1% Brij solution (Sigma). To this final substrate
solution, 8 mmol/liter cysteine were added immediately before
use. The stop solution contained 100 mmol/liter iodoacetate in a
buffer containing 30 mmol/liter sodium acetate and 70 mmol/
liter acetic acid. The pH was 4.75. For preparation of standard
curves, the reaction product NMec was obtained from Bachem
Feinchemikalien, Bubendorf, Switzerland.
Microdissection of tubule segments
For the determination of cathepsins B and L in isolated
segments of proximal tubules, the left kidney was removed
rapidly and perfused with 30 ml of ice-cold collagenase solution
to facilitate microdissection. The kidney was sliced along the
cortico-medullary axis, and the slices were incubated in colla-
genase solution gassed with 100% oxygen in a shaking water
bath at 37°C. Collagenase was used to facilitate dissection. The
segments Si, S2, and S3 of the proximal tubule were microdis-
sected from the slices in dissection solution as described
previously [12]. In the present study Sl was identified as the
first mm of the proximal tubule attached to the glomerulus,
while S2 included the last mm of the proximal convoluted
tubule (S2c) and the first mm of the pars recta (S2r). S3 was
identified as the last mm of the pars recta immediately prior to
the thin descending loop of Henle. The dissected segments were
straightened and the length was measured using an eyepiece
micrometer. The length varied from 300 to 1000 im. Each
segment was then transferred into a second dissection dish with
rinsing solution. After 10 seconds the segments were trans-
ferred with a 2 pi volumetric pipette into a reaction vial
containing 25 s1 of preincubation solution. In each rat, between
three and seven samples of each segment were dissected and
analyzed.
For the determination of cathepsins B and L in homogenates
of kidney cortex and liver, 2 d of the diluted homogenates were
added to 25 1.d of preincubation solution contained in the
reaction vial, and the following steps were identical for isolated
tubule segments and homogenates. The vials were sealed and
frozen in dry ice for ten minutes before preincubation was
initiated. Homogenates were analyzed in duplicates.
Incubation
The samples were preincubated for ten minutes in a shaking
water bath at 37°C. The preincubation in the hypoosmolar
preincubation solution lysed the tubules and tissues completely.
Next, the vials were kept on ice while 25 1.d of substrate solution
were added. At this point the samples were incubated for 30
minutes in a shaking water bath at 37°C. The enzyme reaction
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Table 1. Functional parameters of rats four days, ten days, and six months following induction of diabetes by
rats four and ten days following unilateral nephrectomy (Nx) streptozotocin mi
ection, and of
Creatinine
Kidney wet Glucose Glucose Urine clearance Urine
Body wt wt serum urine volume ml/min/IOO g protein
Group N g mg mgIiOO ml mg124 hr m1124 hr body wt mg/24 hr
4 Days
Control 8 238 7 812 82k' 133 l8U 38 l4 13 2 0.74 0.2 5 2
Diabetes 10 227 16 947 39 502 63 7093 1958 75 31 0.65 0.13 7 2
Sham operated
Unilateral Nx
6
6
232 12 903 35 nm nm 18 3220 9 1036 83" nm nm 17 4 0.81 0.240.52 0b 6 2
10 Days
Control 15 237 6 790 8l 127 l5 18 8 14 a 0.48 0.18 6 2
Diabetes 14 219 16 936 81 417 106 9570 3750 97 29 0.65 0.21 16 6
Diabetes + insulin 10 231 12 847 67 133 soa 1132 580 27 ll 0.44 0.20a 8 4
Sham operated 7 220 13 870 30 nm nm 20 4 0.76 0.22 66 2
Unilateral Nx 7 217 15 1080 90" nm nm 14 6b 0.48 0.12" 5 I
6 Months
Control 9 289 2& 970 l3Oa 127 Ja 21 8 12 4 0.57 o.07 Il 20
Diabetes 10 238 25 1480 220 479 62 5220 920 95 48 0.98 0.32 94 58
Values are mean SD. Abbreviation is nm, not measured
a P < 0.05 versus the respective diabetes groupb p < 0.05 versus unilateral nephrectomy
was stopped by placing the vials on ice and adding 500 sl of stop
solution. To evaluate the background fluorescence due to either
substrate contamination with reaction product or spontaneous
hydrolysis of the substrate during incubation, vials containing
25 d of preincubation solution and 25 d of substrate solution
without nephron segments or tissue homogenate were treated
identically. A standard curve was measured with each experi-
ment.
Measurement of fluorescence
The fluorescence was determined in microcuvettes using a
Turner Model III fluorometer (Turner Assoc., Palo Alto, Cali-
fornia, USA). The sample was excited at 365 nm (Corning filter
CS-7-83), and the emission was recorded at 450 nm (Corning
filter CS-3-72). The enzyme activity in proximal tubule seg-
ments was expressed in pmol of released reaction product
NMec per mm tubule length per minute of incubation time.
Activities of cathepsins B and L in kidney cortex and liver were
expressed in nmol released reaction product per mg protein per
minute of incubation time, The assay was linear with respect to
incubation time, tubule length, and weight of tissue [Ill.
Statistics
Values are given as mean SD. The significance of differ-
ences was tested by Student's t-test. For multiple comparisons
between controls, diabetes, and diabetes + insulin the one-way
analysis of variance (ANOVA) was used. Where ANOVA was
significant, Duncan's multiple-range test was used to identify
group differences. Differences in proteinuria were evaluated by
Wilcoxon's rank sum test. P values < 0.05 were considered
significant.
Results
Effects of ACDC and MHB
Seven non-diabetic rats of the ten day group received daily
injections of depot body (ACDC) and preservative (MHB). This
treatment did not change the values of body weight, kidney
weight, urine volume, creatinine clearance, proteinuria, plasma
glucose, and urine glucose in comparison to control animals (N
8). Activities of cathepsins B and L in proximal tubule
segments remained unchanged. Hence, both groups were taken
together as control group for the following experiments.
Effects of four days diabetes
Rats four days following streptozotocin injection had in-
creased values of serum glucose, glucosuria, and urine volume
(Table 1). The kidney weight was increased by 17% in compar-
ison to controls (P < 0.01). The activities of cathepsins B and L
were decreased in the proximal tubule segments S2c, S2r. and
S3, (P < 0.05 vs. control, respectively) (Fig. 1).
Effects of10 days of diabetes and insulin treatment
Ten days following streptozotocin injection increased values
of blood glucose, urinary glucose, and urine volume were
present (Table I). Kidney wet weight was increased by 19% to
27% (P <0.001), kidney protein content was increased by 20%
(P < 0.03), and kidney water content remained unchanged at
75% (Tables I and 2). The body weight was lower in diabetic
rats (P < 0.05 vs. control), the creatinine clearance was
elevated (P < 0.05 vs. control) and proteinuria was 250% of
control values (P < 0.00 1). Injection of insulin prevented most
of the changes observed in diabetic rats (Tables 1 and 2). Body
weight, kidney weight, kidney water content, kidney protein,
creatinine clearance, urine protein, and serum glucose were not
different from controls. Urine glucose and urine volume were
elevated in the insulin group (P < 0.001 vs. control, respective-
ly). In comparison to diabetic rats, the insulin treated animals
had lower values of kidney weight (P <0.05), kidney protein (P
< 0.05), urine volume, urine protein excretion, creatinine
clearance, blood glucose, and urine glucose (Tables I and 2).
The activities of cathepsins B and L from diabetic rats were
decreased in kidney cortex homogenates (P <0.05 vs. control)
(Table 2), in SI segments (P < 0.01) and in both S2 segments (P
<0.001, respectively; Fig. 2). Insulin treatment prevented the
decrease in activity of cathepsins B and L in the kidney cortex
of streptozotocin injected rats (Table 2). The enzyme activities
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four days as well as at ten days following unilateral nephrec-
tomy.
Discussion
The kidney weight in streptozotocin diabetic rats was in-
creased by 17% at day four, by 18% to 27% at day ten, and by
53% at six months following induction of diabetes in compari-
son to the respective controls. The kidney protein content at ten
days was 20% above control values, and the water content of
the kidneys was the same in diabetics and controls. This
indicates accretion of protein mass in diabetic renal hypertro-
phy, as described previously [12]. Renal hypertrophy was
accompanied by reduction in activities of cathepsins B and L in
S2r S3 both S2 segments and in the S3 segment at four days, and by
reduction in Si and S2 segments at ten days following induction
of diabetes. Streptozotocin-induced diabetes was mitigated by
insulin treatment, and renal hypertrophy as well as the decrease
in cathepsin activities were almost completely prevented by
insulin.
The activities of cathepsins B and L were measured as
marker enzymes for the proteolytic activity in the lysosomes.
The assay is specific and sensitive, and the control values in
proximal tubule segments were similar to previously reported
data [11]. Cathepsin analysis in isolated tubule segments with
relation of enzyme activity to tubule length was applied since
the usual relation of enzyme activity to mg protein in tissue
homogenates is difficult to interpret in the context of renal
hypertrophy. A hypothetical kidney cell may contain 100 mg of
protein and 100 units of cathepsin. The enzyme activity would
be 1 U/mg. Reduction of the activity to 0.66 units per mg protein
in the presence of cell hypertrophy could indicate: (1) reduced
absolute activity, 80 U/120 mg protein; (2) unchanged absolute
activity, 100 U/150 mg protein; and (3) increased absolute
activity, 120 U/180 mg protein. Important for the role of
cathepsins in relation to cell hypertrophy is the absolute en-
zyme activity per cell. Relation of enzyme activity to tubule
length is a close approach to this optimal experimental design.
However, determinations of cathepsin activities in renal cortex
were performed in the present study to enable comparisons
with liver cathepsin activities and with the results of other
authors.
Factors that must be considered in the interpretation of the
decreased cathepsin activities in diabetic animals include strep-
tozotocin, the presence of proteinuria, renal hypertrophy per
Se, and diabetes mellitus. The prevention of the cathepsin
reduction in kidneys of streptozotocin-injected rats by insulin
excludes streptozotocin as a causal factor. Proteinuria stimu-
lates cathepsin activity in the proximal tubule, and decreased
enzyme activities may be related to reduced proteinuria [11].
This explanation appears unlikely since proteinuria in the
diabetic rats was increased. Renal hypertrophy could be accom-
panied by a decrease in cathepsin activity. Proximal tubule
length increases in diabetic and compensatory renal growth [2,
5], and enzyme activity was related to tubule length in the
present study. Hence, it is conceivable that the true cathepsin
activity remained unchanged, while the measured activity was
decreased due to "dilution" in a longer tubule. This can be
excluded since compensatory renal growth of similar magnitude
and duration after unilateral nephrectomy was not accompanied
by a decrease in cathepsin activities. Furthermore, the normal
25
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Fig. 1. Activities of cathepsins B and L in microdissected proximal
tubule segments from rats four days following injection of streptozo-
tocin and controls. SI, the first mm of the proximal tubule attached to
the glomerulus. S2c, the last mm of the proximal convoluted tubule.
S2r, the first mm of the pars recta. S3, the last mm of the pars recta
immediately prior to the thin descending loop of Henle. Open bars
represent values from control rats (N = 8). Dark bars represent values
from streptozotocin-diabetic rats (N = 10). Data are mean so. The
asterisks indicate P < 0.05 versus control.
in Si and S2 segments from insulin treated rats were not
different from activities in control rats. In comparison to
diabetic rats, activities of cathepsins B and L were higher in S2r
(P < 0.005) and in S2c (P < 0.001), but were not different in Si
and in S3 (Fig. 2).
The liver weight in diabetic rats was decreased by 29% and
activity of cathepsins B and L was increased by 52% (P <
0.001, respectively; Table 2).
Effects of six month diabetes
The rats had increased values of blood glucose, urine glucose
and urine volume (Table 1). Creatinine clearance and protein-
uria were elevated. The kidney weight was increased by 53%.
The body weight was lower than in control animals. The
activities of cathepsins B and L in the three segments of the
proximal tubule were not different in diabetic and control rats,
as shown in Figure 3.
Effects of unilateral nephrectomy
Unilateral nephrectomy had no effect on body weight, pro-
teinuria, and urine volume (Table 1). Kidney weight increased
by 15% after four days (P < 0.05) and by 28% after ten days (P
<0.001). The creatinine clearance of the left kidney following
contralateral nephrectomy was increased in comparison to 50%
of the clearance of sham operated rats in both groups (P <
0.005, respectively). Activities of cathepsins B and L are
depicted in Figure 4. No differences in cathepsin activities from
four days and ten days in sham operated rats were present.
Therefore, the values of both groups are presented together in
one column. A significant increase in comparison to controls
occurred in the 52r segment of the proximal tubule four days
following unilateral nephrectomy (P < 0.02). The activities of
cathepsins B and L in all other segments remained unchanged at
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Table 2. Body weight, kidney weight and water content, kidney protein, liver weight, and cathepsin B and L activities in kidney and liver
homogenates of diabetic and non-diabetic rats
Cathespins Cathespins
Kidney B and L B and L
Kidney wet water Kidney kidney Liver wet liver
Body wt wt content protein nmol/minl wt nmol/min/
Group N g mg % mg mg protein g mg protein
10 Days
Control 12 228 l3 744 51 75.6 2.1 87 ioa 174 188 8.6 0.98 25 5.8a
Diabetes 10 209 7 945 93 74.8 2.3 104 11 131 31 6.1 0,3 38 5.9
Diabetes + insulin 7 228 58 809 478 72.7 2.4 81 19b 223 838 nm nm
Values are mean SD. Abbreviation is nm, not measured.
P < 0.05 versus Diabetes
Fig. 2. Activities of cathepsins B and L in microdissected proximal
tubule segments from rats ten days following injection of streptozotocin
and controls. SI, the first mm of the proximal tubule attached to the
glomerulus. S2c, the last mm of the proximal convoluted tubule. S2r,
the first mm of the pars recta. S3, the last mm of the pars recta
immediately prior to the thin descending loop of Henle. Open bars
represent values from control rats (N 15). Dark bars represent values
from streptozotocin-diabetic rats (N 14). Hatched bars represent
values from streptozotocin-diabetic rats treated with insulin (N = 10).
Data are mean SD. The asterisks indicate P < 0.05 versus untreated
diabetic rats.
T Tii
Proximal tubule segment
S3
Fig. 3. Activities of cathepsins B and L in microdissected proximal
tubule segments from rats six months following injection of streptozo-
tocin and controls. SI, the first mm of the proximal tubule attached to
the glomerulus. S2c, the last mm of the proximal convoluted tubule. S3,
the last mm of the pars recta immediately prior to the thin descending
loop of Henle. Open bars represent values from control rats (N = 9).
Dark bars represent values from streptozotocin diabetic rats (N = 10),
Data are mean SD.
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cathepsin activities in proximal tubule segments from six-
month-old diabetic rats in the presence of marked renal hyper-
trophy argue against renal hypertrophy as a causal factor for
cathepsin reduction. Therefore, we believe that metabolic
and/or functional changes related to the early diabetic state may
be responsible for the decreased cathepsin activities in proximal
tubule segments. Consistent with our results is the finding of
reduced cathepsin D activity, another lysosomal proteinase, in
kidney cortex homogenates from diabetic animals [13—151.
It is conceivable that the decreased cathepsin activities
contribute to the development of diabetic renal hypertrophy for
the following reasons. The cathepsin activities are reduced in
the proximal tubule and diabetic renal hypertrophy involves
proximal tubule [2]. A general decrease in cathepsin activities in
early diabetes independent of organ hypertrophy was excluded
by the finding of increased activities of cathepsins B and L in
the liver and reduced liver weight. This is in agreement with
data reported by others, showing a reduced protein content and
increased rates of protein degradation in liver, muscle, and
heart from diabetic rats [3, 14—19]. It should be mentioned,
however, that some authors found increased activities of lyso-
somal proteases in muscle of diabetic animals [20], while others
could not confirm these findings [211. A decrease in cathepsin
activities with a concomitant increase in protein mass is ob-
served only in the kidney of diabetic rats. Furthermore, treat-
ment of streptozotocin diabetic rats with insulin prevented renal
hypertrophy and cathepsin decrease. Also consistent with the
hypothesis of a causal relationship between reduced cathepsin
activities and diabetic renal hypertrophy are the unchanged
cathepsin activities in tubule segments from six-month-old
diabetic rats. Renal hypertrophy is complete at that time. No
further accretion of protein occurs [12], and proteolytic enzyme
activities return to normal values.
The interpretation of the results depends on the critical
question if reduced cathepsin activities reflect decreased cellu-
lar protein degradation. While we do not have direct proof that
cathepsins B and L in the kidney indicate activities of cell
protein degradation, several lines of evidence suggest a tight
Olbricht and Geissinger: Diabetic renal hypertrophy and proteolytic enzymes 971
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Fig. 4. Activities of cathepsins B and L in microdissected proximal
tubule segments from rats with compensatory renal hypertrophy four
days and ten days following unilateral nephrectomy and from sham
operated controls. SI, the first mm of the proximal tubule attached to
the glomerulus. S2c, the last mm of the proximal convoluted tubule.
S2r, the first mm of the pars recta. S3, the last mm of the pars recta
immediately prior to the thin descending loop of Henle. Open bars
represent values from sham operated rats (N = 13). Dark bars represent
values four days following unilateral nephrectomy (N = 6). Hatched
bars represent values from rats ten days following unilateral nephrec-
tomy (N = 4). Data are mean so. The asterisks indicate P < 0.05
versus sham operated rats.
ever, further experimental data are needed to substantiate this
hypothesis.
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